 CAMBRIDGE, Mass., Jan. 03, 2023 GLOBE NEWSWIRE -- EQRx, Inc. Nasdaq: EQRX, a new type of pharmaceutical company committed to developing and expanding access to innovative medicines for some of the most prevalent disease areas, including cancer and immune-inflammatory conditions, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 4:30 p.m. PST 7:30 p.m. EST. 